High concentrations of diazepam-binding inhibitor (DBI) mRNA have been dete
cted in astrocytoma, suggesting that DBI-derived peptides may play a role i
n glial cell proliferation. In the present study, we have investigated the
effect of a processing product of DBI, the octadecaneuropeptide ODN, on DNA
synthesis in cultured rat astrocytes. At very low concentrations (10(-14)
to 10(-11) M), ODN caused a dose-dependent increase of [H-3]thymidine incor
poration. At higher doses (10(-10) to 10(-5) M), the effect of ODN graduall
y declined. The central-type benzodiazepine receptor antagonist flumazenil
(10(-6) M) completely suppressed the stimulatory action of ODN whereas the
peripheral-type benzodiazepine receptor ligand, PK11195 (10(-6) M) had no e
ffect. The ODN-induced stimulation of [H-3]thymidine incorporation was mimi
cked by methyl 6,7-dimethoxy-4-ethyl-beta-carboline-3-carboxylate (DMCM). T
he GABA(A) receptor antagonist bicuculline (10(-4) M) suppressed the effect
of both ODN and DMCM on DNA synthesis. Exposure of cultured astrocytes to
the specific GABA(A) agonist 3APS (10(-10) to 10(-4) M) also induced a dose
-related increase of [H-3]thymidine incorporation. The present study indica
tes that ODN, acting through central-type benzodiazepine receptors associat
ed with the GABA(A) receptor complex, stimulates DNA synthesis in rat glial
cells. These data provide evidence for an autocrine role of endozepines in
the control of glial cell proliferation. (C) 1999 Elsevier Science Ltd. Al
l rights reserved.